Austria's total pharmaceutical sales are projected to continue their steady growth from 2024 to 2028. In 2023, the market stood at 5.34 Billion US Dollars PPP. Forecasted sales for 2024 are estimated at 5.55 Billion US Dollars PPP, increasing to 6.37 Billion US Dollars PPP by 2028. The year-on-year growth rate between 2024 and 2025 is about 3.8%, and it remains relatively consistent with a 3.6% increase each subsequent year. The Compound Annual Growth Rate (CAGR) over these five years is approximately 3.6%.

Future trends to watch for include:

Advancements in pharmaceutical technology and biotechnology that could drive growth.
The impact of regulatory changes in Austria and the EU that may affect market dynamics.
Increased focus on personalized medicine and its potential market implications.
Economic conditions that could either bolster or hinder market growth, such as inflation or healthcare funding adjustments.